Neurodegenerative Disease Research
Neurodegenerative diseases are conditions that slowly damage the brain and nerves, leading to problems with learning and memory, movement, and thinking. Examples include Alzheimer's, which affects memory, and Parkinson's, which affects movement. These diseases are usually caused by a mix of genetics and environmental factors. These conditions get worse over time and there are currently no cures, however, treatments can help manage the symptoms.
Learn about using biochemical assays, cell viability, and organoids for screening new drug candidates for most common neurodegenerative disease Alzheimer’s and Parkinson’s.
- Can Organoids Unlock the Pathology of Traumatic Brain Injuries
- Functional characterization of healthy Alzheimer’s disease-related 3D neurospheres formed using human iPSC-derived glutamatergic neurons, GABAergic neurons, and astrocytes
- Functional and morphological characterization of healthy and epilepsy-related 3D neurospheres assembled using iPSC-derived neurons and astrocytes
- Empower breakthroughs in neurodegenerative research with microplate readers
- Oxford Drug Discovery Institute uses the FLIPR System to explore therapeutic mechanisms for neurodegenerative diseases
- ETAP Lab use the SpectraMax i3x to advance neurodegenerative disease research
- Functional characterization of healthy and disease-related 3D neurospheres assembled using human iPSC-derived neurons and astrocytes